Topical application of superoxide dismutase mediated by HIV-TAT peptide attenuates UVB-induced damages in human skin

Xiaochao Chen, Shutao Liu, Pingfan Rao, Jeremy Bradshaw, Richard Weller

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The purpose of this study was to evaluate whether topical application of superoxide dismutase with cell penetrating peptide (HIV-TAT) could protect against skin damage induced by UVB irradiation in humans. The permeability through stratum corneum of large proteins linked to TAT peptide was firstly confirmed by confocal microscopy and tape stripping. Ten healthy volunteers with either Fitzpatrick skin type II or III were recruited in this clinical study. TAT-SOD (300 units/cm2) and vehicle cream were applied on two symmetric areas of both inner upper arms 1 h prior to UVB irradiation. After one hour of pretreatment, subjects received 10 incremental doses of UVB on pretreated areas. 24 h later, erythema, blood flow and apoptotic cells were measured. Pretreatment with TAT-SOD 1 h prior to UVB radiation promoted a mean minimal erythema dose (MED) increase of 36.6 ± 18.4% (p = 0.013 < 0.05. n = 10) compared to vehicle control. The median blood flow values of all subjects following 2 and 3-MED of UVB were 107.8 ± 51.0 units and 239.5 ± 88.0 units respectively, which account for 26% and 25% decrease with respect to vehicle groups. These data suggest that TAT-SOD significantly suppresses UVB induced erythema formation and blood flow rise. Furthermore, pretreatment with TAT-SOD 1 h prior to 2-MED of UVB irradiation reduced the apoptotic sunburn cell formation by 47.6 ± 8.6% (p < 0.0001) in all subjects. Evaluating results generated from all measurements, we conclude that topical application of TAT-SOD significantly attenuates UVB-induced skin damage in man. These biological effects of TAT-SOD are probably mediated via its free radical scavenging properties, clearly differentiating it from other physical sunscreen agents.

Original languageEnglish
Pages (from-to)286-294
Number of pages9
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume107
Early online date25 Jul 2016
DOIs
Publication statusPublished - 1 Oct 2016

Keywords

  • Blood flow
  • Erythema
  • HIV-TAT peptide
  • Sunburn cell
  • Superoxide dismutase
  • Tape stripping
  • Transdermal delivery
  • Ultraviolet

ASJC Scopus subject areas

  • Biotechnology
  • Pharmaceutical Science

Cite this

Topical application of superoxide dismutase mediated by HIV-TAT peptide attenuates UVB-induced damages in human skin. / Chen, Xiaochao; Liu, Shutao; Rao, Pingfan; Bradshaw, Jeremy; Weller, Richard.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 107, 01.10.2016, p. 286-294.

Research output: Contribution to journalArticle

@article{94e97a1e0dd04aff80b539bbc38f24e2,
title = "Topical application of superoxide dismutase mediated by HIV-TAT peptide attenuates UVB-induced damages in human skin",
abstract = "The purpose of this study was to evaluate whether topical application of superoxide dismutase with cell penetrating peptide (HIV-TAT) could protect against skin damage induced by UVB irradiation in humans. The permeability through stratum corneum of large proteins linked to TAT peptide was firstly confirmed by confocal microscopy and tape stripping. Ten healthy volunteers with either Fitzpatrick skin type II or III were recruited in this clinical study. TAT-SOD (300 units/cm2) and vehicle cream were applied on two symmetric areas of both inner upper arms 1 h prior to UVB irradiation. After one hour of pretreatment, subjects received 10 incremental doses of UVB on pretreated areas. 24 h later, erythema, blood flow and apoptotic cells were measured. Pretreatment with TAT-SOD 1 h prior to UVB radiation promoted a mean minimal erythema dose (MED) increase of 36.6 ± 18.4{\%} (p = 0.013 < 0.05. n = 10) compared to vehicle control. The median blood flow values of all subjects following 2 and 3-MED of UVB were 107.8 ± 51.0 units and 239.5 ± 88.0 units respectively, which account for 26{\%} and 25{\%} decrease with respect to vehicle groups. These data suggest that TAT-SOD significantly suppresses UVB induced erythema formation and blood flow rise. Furthermore, pretreatment with TAT-SOD 1 h prior to 2-MED of UVB irradiation reduced the apoptotic sunburn cell formation by 47.6 ± 8.6{\%} (p < 0.0001) in all subjects. Evaluating results generated from all measurements, we conclude that topical application of TAT-SOD significantly attenuates UVB-induced skin damage in man. These biological effects of TAT-SOD are probably mediated via its free radical scavenging properties, clearly differentiating it from other physical sunscreen agents.",
keywords = "Blood flow, Erythema, HIV-TAT peptide, Sunburn cell, Superoxide dismutase, Tape stripping, Transdermal delivery, Ultraviolet",
author = "Xiaochao Chen and Shutao Liu and Pingfan Rao and Jeremy Bradshaw and Richard Weller",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.ejpb.2016.07.023",
language = "English",
volume = "107",
pages = "286--294",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",

}

TY - JOUR

T1 - Topical application of superoxide dismutase mediated by HIV-TAT peptide attenuates UVB-induced damages in human skin

AU - Chen, Xiaochao

AU - Liu, Shutao

AU - Rao, Pingfan

AU - Bradshaw, Jeremy

AU - Weller, Richard

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The purpose of this study was to evaluate whether topical application of superoxide dismutase with cell penetrating peptide (HIV-TAT) could protect against skin damage induced by UVB irradiation in humans. The permeability through stratum corneum of large proteins linked to TAT peptide was firstly confirmed by confocal microscopy and tape stripping. Ten healthy volunteers with either Fitzpatrick skin type II or III were recruited in this clinical study. TAT-SOD (300 units/cm2) and vehicle cream were applied on two symmetric areas of both inner upper arms 1 h prior to UVB irradiation. After one hour of pretreatment, subjects received 10 incremental doses of UVB on pretreated areas. 24 h later, erythema, blood flow and apoptotic cells were measured. Pretreatment with TAT-SOD 1 h prior to UVB radiation promoted a mean minimal erythema dose (MED) increase of 36.6 ± 18.4% (p = 0.013 < 0.05. n = 10) compared to vehicle control. The median blood flow values of all subjects following 2 and 3-MED of UVB were 107.8 ± 51.0 units and 239.5 ± 88.0 units respectively, which account for 26% and 25% decrease with respect to vehicle groups. These data suggest that TAT-SOD significantly suppresses UVB induced erythema formation and blood flow rise. Furthermore, pretreatment with TAT-SOD 1 h prior to 2-MED of UVB irradiation reduced the apoptotic sunburn cell formation by 47.6 ± 8.6% (p < 0.0001) in all subjects. Evaluating results generated from all measurements, we conclude that topical application of TAT-SOD significantly attenuates UVB-induced skin damage in man. These biological effects of TAT-SOD are probably mediated via its free radical scavenging properties, clearly differentiating it from other physical sunscreen agents.

AB - The purpose of this study was to evaluate whether topical application of superoxide dismutase with cell penetrating peptide (HIV-TAT) could protect against skin damage induced by UVB irradiation in humans. The permeability through stratum corneum of large proteins linked to TAT peptide was firstly confirmed by confocal microscopy and tape stripping. Ten healthy volunteers with either Fitzpatrick skin type II or III were recruited in this clinical study. TAT-SOD (300 units/cm2) and vehicle cream were applied on two symmetric areas of both inner upper arms 1 h prior to UVB irradiation. After one hour of pretreatment, subjects received 10 incremental doses of UVB on pretreated areas. 24 h later, erythema, blood flow and apoptotic cells were measured. Pretreatment with TAT-SOD 1 h prior to UVB radiation promoted a mean minimal erythema dose (MED) increase of 36.6 ± 18.4% (p = 0.013 < 0.05. n = 10) compared to vehicle control. The median blood flow values of all subjects following 2 and 3-MED of UVB were 107.8 ± 51.0 units and 239.5 ± 88.0 units respectively, which account for 26% and 25% decrease with respect to vehicle groups. These data suggest that TAT-SOD significantly suppresses UVB induced erythema formation and blood flow rise. Furthermore, pretreatment with TAT-SOD 1 h prior to 2-MED of UVB irradiation reduced the apoptotic sunburn cell formation by 47.6 ± 8.6% (p < 0.0001) in all subjects. Evaluating results generated from all measurements, we conclude that topical application of TAT-SOD significantly attenuates UVB-induced skin damage in man. These biological effects of TAT-SOD are probably mediated via its free radical scavenging properties, clearly differentiating it from other physical sunscreen agents.

KW - Blood flow

KW - Erythema

KW - HIV-TAT peptide

KW - Sunburn cell

KW - Superoxide dismutase

KW - Tape stripping

KW - Transdermal delivery

KW - Ultraviolet

UR - http://www.scopus.com/inward/record.url?scp=84979988103&partnerID=8YFLogxK

U2 - 10.1016/j.ejpb.2016.07.023

DO - 10.1016/j.ejpb.2016.07.023

M3 - Article

VL - 107

SP - 286

EP - 294

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -